Pfizer’s Center for Digital Innovation (CDI) received the high distinction «Honored Digital Innovation Company» award of the word-class Pharmaceuticals Awards, Prix Galien, at the 6th Awards Ceremony, which took place on April 5th 2023, at Athens Concert Hall.
The award, which coincides with the completion of ten years of Prix Galien's presence in Greece, is a recognition of CDI's work in the field of digital innovation in Health sector. This project, which currently engages more than 400 highly qualified young professionals at CDI's site in Thessaloniki, in addition to the development of innovative solutions that change patients’ lives has contributed substantially to the development of Thessaloniki into a global hub of innovation.
"I am honored and proud to accept this award on behalf of everyone at Pfizer's Center for Digital Innovation – from all the colleagues in Thessaloniki and around the world" said Nico Gariboldi, CDI Lead, upon receiving the award, and added: “We feel very proud of our partnership with the innovation ecosystem in Greece. This award is not only for CDI and Pfizer, but also for all our partners, Universities, research centers, foundations and start-ups that we have worked closely during these 3 years to accelerate breakthroughs that change patients' lives."
